These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 25945010)
1. Prognostic value of neutrophil distribution in cholangiocarcinoma. Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010 [TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma. Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260 [TBL] [Abstract][Full Text] [Related]
3. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of C-met Expression in Cholangiocarcinoma. Mao ZY; Zhu GQ; Ren L; Guo XC; Su D; Bai L Technol Cancer Res Treat; 2016 Apr; 15(2):227-33. PubMed ID: 25873560 [TBL] [Abstract][Full Text] [Related]
5. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma. Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669 [TBL] [Abstract][Full Text] [Related]
6. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma. Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191 [TBL] [Abstract][Full Text] [Related]
7. High expression of CD11c indicates favorable prognosis in patients with gastric cancer. Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367 [TBL] [Abstract][Full Text] [Related]
8. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma. Zhang JW; Chu YM; Lan ZM; Tang XL; Chen YT; Wang CF; Che X World J Gastroenterol; 2015 Apr; 21(14):4255-60. PubMed ID: 25892876 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases. Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644 [TBL] [Abstract][Full Text] [Related]
10. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638 [TBL] [Abstract][Full Text] [Related]
11. CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection. Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Shimada M Anticancer Res; 2017 Oct; 37(10):5701-5705. PubMed ID: 28982889 [TBL] [Abstract][Full Text] [Related]
12. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148 [TBL] [Abstract][Full Text] [Related]
14. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094 [TBL] [Abstract][Full Text] [Related]
15. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598 [TBL] [Abstract][Full Text] [Related]
16. Elevated expression of G Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784 [TBL] [Abstract][Full Text] [Related]
17. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642 [TBL] [Abstract][Full Text] [Related]
18. Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma. Lin G; Liu Y; Li S; Mao Y; Wang J; Shuang Z; Chen J; Li S Oncotarget; 2016 Aug; 7(32):50963-50971. PubMed ID: 26918355 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma. Sun Q; Li F; Sun F; Niu J Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407 [TBL] [Abstract][Full Text] [Related]
20. High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma. Sun Q; Zhao C; Xia L; He Z; Lu Z; Liu C; Jia M; Wang J; Niu J Int J Clin Exp Pathol; 2014; 7(9):6157-64. PubMed ID: 25337264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]